Universal screening for SARS-CoV-2 in pregnant women admitted for delivery: how to manage antibody testing?
J Matern Fetal Neonatal Med
.
2022 Aug;35(15):3005-3006.
doi: 10.1080/14767058.2020.1793317.
Epub 2020 Jul 28.
Authors
Anna Franca Cavaliere
1
,
Alis Iuliana Carabaneanu
1
,
Federica Perelli
2
,
Daniela Matarrese
3
,
Tamara Brunelli
4
,
Patrizia Casprini
4
,
Pier Luigi Vasarri
5
Affiliations
1
Gynecology and Obstetric Division, Azienda USL Toscana Centro, Santo Stefano Hospital, Prato, Italy.
2
Gynecology and Obstetric Division, Azienda USL Toscana Centro, Santa Maria Annunziata Hospital, Florence, Italy.
3
Azienda USL Toscana Centro, Santo Stefano Hospital, Prato, Italy.
4
Clinical Chemistry and Microbiology Laboratory, Azienda USL Toscana Centro, Santo Stefano Hospital, Prato, Italy.
5
Department of Pediatrics, Azienda USL Toscana Centro, Santo Stefano Hospital, Prato, Italy.
PMID:
32722953
DOI:
10.1080/14767058.2020.1793317
No abstract available
Publication types
Letter
MeSH terms
COVID-19 Testing
COVID-19*
Clinical Laboratory Techniques
Female
Humans
Pregnancy
Pregnancy Complications, Infectious* / diagnosis
Pregnant Women
SARS-CoV-2